Yes, the truth is starting to come out.
Gradually and so smoothly, the pumpers' tune will change to: "Spectral was the best vehicle to complete the trial, but now Vantive is where it's at". They are not there yet, but "$ 1.60 is a bit conservative" is the new basis for their communication strategy.
Spectral is no longer a potentiel 6-16 dollar stock that was promoted here for years until recently.
There are only 2 likely outcomes for Spectral.
1 - The trial is a success, but whatever independant value Spectral has (rights holder with no production or distribution capacity) is swallowed before it gets the chance to pop on the stock market ("but hey, we got from 30 cents to 75 cents, you can't complain").
2 - The trial is not that successful or has limited real world applicability, and, well...